Fundz

Twister Biotech, Inc. reported raising $1.12 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEJan 11, 2021

Amount Raised

$1.12 Million

$1.12 Million sold, per SEC Form D (first sale Jan 11, 2021)

Round Type

Seed

HoustonBiotechnology

Who to call at Twister Biotech, Inc., and when

A new round usually means Twister Biotech, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Twister Biotech, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Twister Biotech, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Twister Biotech, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Twister Biotech, Inc.

Location

4108 LILLIAN ST., UNIT B

Houston, Texas, United States

About

Twister Biotech was created around the break-through and disruptive platform technology, MiniVectors, that originated in the laboratory of Dr. Lynn Zechiedrich at Baylor College of Medicine. MiniVectors are supercoiled DNA minicircles containing ONLY the sequence of interest, as small as a few hundred base pairs, compared to traditional plasmids that are orders of magnitude larger. Experiments have demonstrated that MiniVectors are a safe and effective platform for getting DNA into “difficult-to-transfect” cells, such as primary and stem cells. Twister’s primary mission is to provide MiniVectors to researchers to enable better transfection efficiencies and allow longer-term effects to be observed.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Twister Biotech, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLynn Z., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Twister Biotech, Inc.'s next move

See what Strategic adds

Twister Biotech, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.